Wordt geladen...
COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment
COVID-19 disease increases interleukin (IL)-1β release. Anti-IL-1-treatment is effective in IL-1-mediated autoinflammatory diseases (AID). This case series presents COVID-19 in patients with IL-1-mediated and unclassified AID with immunosuppressive therapy (IT). Patient 1 is a 34-year-old woman with...
Bewaard in:
| Gepubliceerd in: | J Clin Med |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7915607/ https://ncbi.nlm.nih.gov/pubmed/33562758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040605 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|